| Entry |
|
| Name |
Aluminum silicate hydrate with silicon dioxide (JP19); Hydrated halloysite; Talcum crystallinum; Kasseki |
| Component |
Natural aluminum silicate [DR: D03237], Silicon dioxide [DR: D06521]
|
| Remark |
| Therapeutic category: | 5100 |
|
| Efficacy |
Diuretic |
| Comment |
Clay mineral comprised of natural hydrated aluminium silicate and silicon dioxide; Standards for non-pharmacopoeial crude drugs
|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
5 Crude drugs and Chinese medicine formulations
51 Crude drugs
510 Crude drugs
5100 Crude drugs
D06895 Aluminum silicate hydrate with silicon dioxide (JP19)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Crude drugs
Talcum crystallinum
D06895 Aluminum silicate hydrate with silicon dioxide (JP19)
Third-class OTC drugs
Crude drugs
Talcum crystallinum
D06895 Aluminum silicate hydrate with silicon dioxide (JP19)
Traditional Chinese Medicine in Japan [BR:br08304]
Crude drugs
Drugs for dampness
Diuretic drugs
D06895 Talcum crystallinum; Kadinum; Kasseki
Crude drugs [BR:br08305]
Others
Minerals
D06895 Hydrated halloysite
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Crude drugs
D06895 Aluminum silicate hydrate with silicon dioxide
|
| Other DBs |
|
| LinkDB |
|